Skip to main content
. 2021 Apr 18;13(8):1952. doi: 10.3390/cancers13081952

Figure 4.

Figure 4

Plots C-E: Kaplan–Meier survival curves showing pre-treatment plasma VEGF-A (A), plasma sVEGFR1 (B) and sVEGFR2/sVEGFR1 ratio (C) in IBrC patients, divided according to cut-offs: for VEGF-A, <64.11 and >64.11 pg/mL; sVEGFR1, <29.86 and >29.86 pg/mL and sVEGFR2/sVEGFR1 ratios, <367.04 and >367.04.